"One of the things that we've shown, in particular, is that it's not stent, not the coating, it's not the drug, but all of the things" that may result in injury to the artery. "Indeed, that is one of the very important parts of what we've found."

— Elazer Edelman, MD, PhD, the Thomas D. and Virginia W. Cabot Professor of Health Science and Technology (HST) at MIT, describing why all three elements of a drug-eluting stent must be considered in the development process, "Mathematical model offers some answers for more effective DES."